Gateway to China: Developing Biologics for the Fastest-Growing Patient Population on Earth

Date: Thursday, January 12, 2023
Time: 9:30am CET / 4:30pm China time
Duration: 1 hour

China is the world’s second-largest pharmaceutical market, following the US, with a market share around 12% in global pharmaceutical sales in 2021.* With an aging population and the rise of new indications, this population makes an attractive market for any biopharmaceutical company. In this webinar, hear from Yan Fang Ma, general manager of Thermo Fisher’s site in Hangzhou, China, as she describes the opportunities and challenges multinational companies may face bringing biologics and sterile drug products to market in China and the how the right CDMO partner can provide trusted guidance along the way.

Join us for the webinar with Yan Fang Ma, vice president and site general manager for Thermo Fisher’s new CDMO site in Hangzhou, China.

Key Topics
  • What makes China an attractive market for biopharmaceutical companies?
  • What challenges do these companies face to develop and manufacture drugs in China?
  • What factors to keep in mind when choosing a CDMO partner to enter the China market
Yan Fang Ma
Vice President & General Manager - Hangzhou, China
Thermo Fisher Scientific

Yan Fang is the Vice President & General Manager of Thermo Fisher Scientific’s site in Hangzhou, China. As a part of the pharma services global network, the Hangzhou site provides end-to-end biologics drug substance and drug product manufacturing, cell line development and process development services in China.

Yan Fang has more than 25 years of industrial experience in vaccine and biologics process industrialization and commercialization, tech transfer and CMC management including 21 years at Sanofi. Prior to joining Thermo Fisher, Yan Fang was Head of CMC New Product Program for China & Asia Pacific at Sanofi, responsible for managing CMC programs to enable product registration and commercial launch in China and Japan. For 5 years, Yan Fang had headed Sanofi Pasteur’s global tech transfer function.
Christy Eatmon
Global SME, Sterile Drug Products
Thermo Fisher Scientific
Register Now for FREE
e.g. Pharmaceutical Manufacturing/API Producer/New Drug R&D/Pharmaceutical Engineering/Laboratory Services/Packaging Solution, etc.
Check here to confirm you acknowledge that CPHI China, part of Informa Markets, is providing you with this webinar free of charge and you may be contacted by us and the sponsors with relevant information about our products and services.